BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

344 related articles for article (PubMed ID: 31828583)

  • 1. Predictive Factors for Lateral Lymph Node Metastasis and Skip Metastasis in Papillary Thyroid Carcinoma.
    Feng JW; Qin AC; Ye J; Pan H; Jiang Y; Qu Z
    Endocr Pathol; 2020 Mar; 31(1):67-76. PubMed ID: 31828583
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk factors for skip metastasis and lateral lymph node metastasis of papillary thyroid cancer.
    Zhao H; Huang T; Li H
    Surgery; 2019 Jul; 166(1):55-60. PubMed ID: 30876667
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Skip metastasis in papillary thyroid carcinoma is difficult to predict in clinical practice.
    Nie X; Tan Z; Ge M
    BMC Cancer; 2017 Oct; 17(1):702. PubMed ID: 29070029
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk factor analysis for predicting cervical lymph node metastasis in papillary thyroid carcinoma: a study of 966 patients.
    Liu C; Xiao C; Chen J; Li X; Feng Z; Gao Q; Liu Z
    BMC Cancer; 2019 Jun; 19(1):622. PubMed ID: 31238891
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PTC located in the upper pole is more prone to lateral lymph node metastasis and skip metastasis.
    Dou Y; Hu D; Chen Y; Xiong W; Xiao Q; Su X
    World J Surg Oncol; 2020 Jul; 18(1):188. PubMed ID: 32723382
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictive factors for central lymph node and lateral cervical lymph node metastases in papillary thyroid carcinoma.
    Feng JW; Yang XH; Wu BQ; Sun DL; Jiang Y; Qu Z
    Clin Transl Oncol; 2019 Nov; 21(11):1482-1491. PubMed ID: 30879178
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Skip lateral lymph node metastasis leaping over the central neck compartment in papillary thyroid carcinoma.
    Lei J; Zhong J; Jiang K; Li Z; Gong R; Zhu J
    Oncotarget; 2017 Apr; 8(16):27022-27033. PubMed ID: 28223546
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk Factors for and Prediction Model of Skip Metastasis to Lateral Lymph Nodes in Papillary Thyroid Carcinoma.
    Hu D; Lin H; Zeng X; Wang T; Deng J; Su X
    World J Surg; 2020 May; 44(5):1498-1505. PubMed ID: 31863139
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictive factors of skip metastases to lateral neck compartment leaping central neck compartment in papillary thyroid carcinoma.
    Lim YC; Koo BS
    Oral Oncol; 2012 Mar; 48(3):262-5. PubMed ID: 22047924
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lateral lymph node metastasis in papillary thyroid carcinoma: results of therapeutic lymph node dissection.
    Chung YS; Kim JY; Bae JS; Song BJ; Kim JS; Jeon HM; Jeong SS; Kim EK; Park WC
    Thyroid; 2009 Mar; 19(3):241-6. PubMed ID: 19265495
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk factors associated with preferential lateral lymph node metastasis in papillary thyroid carcinoma.
    Shao L; Wang Z; Dong W; Sun W; Zhang H
    Cancer Med; 2023 Nov; 12(22):20670-20676. PubMed ID: 37905599
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predicting skip metastasis in lateral lymph nodes of papillary thyroid carcinoma based on clinical and ultrasound features.
    Zhao M; Shi X; Zou Z; Wen R; Lu Y; Li J; Cao J; Zhang B
    Front Endocrinol (Lausanne); 2023; 14():1151505. PubMed ID: 37229457
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pattern of and clinicopathologic risk factors for lateral lymph node metastases in papillary thyroid carcinoma patients with lateral cervical lymphadenopathy.
    Gong Y; Yang J; Yan S; Su A; Liu F; Gong R; Zhu J; Li Z
    Medicine (Baltimore); 2018 Sep; 97(36):e12263. PubMed ID: 30200164
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictive factors of lateral lymph node metastasis in solitary papillary thyroid microcarcinoma without gross extrathyroidal extension.
    Zhang X; Zhang L; Xue S; Wang P; Chen G
    Asian J Surg; 2019 Apr; 42(4):563-570. PubMed ID: 30078501
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The utility of sentinel Lymph node biopsy in the lateral neck in papillary thyroid carcinoma.
    Yan XQ; Ma ZS; Zhang ZZ; Xu D; Cai YJ; Wu ZG; Zheng ZQ; Xie BJ; Cao FL
    Front Endocrinol (Lausanne); 2022; 13():937870. PubMed ID: 35957824
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk Factors and a Prediction Model of Lateral Lymph Node Metastasis in CN0 Papillary Thyroid Carcinoma Patients With 1-2 Central Lymph Node Metastases.
    Wang Y; Deng C; Shu X; Yu P; Wang H; Su X; Tan J
    Front Endocrinol (Lausanne); 2021; 12():716728. PubMed ID: 34721289
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Specific Predicting Model for Screening Skip Metastasis From Patients With Negative Central Lymph Nodes Metastasis in Papillary Thyroid Cancer.
    Yang Z; Heng Y; Zhao Q; Cao Z; Tao L; Qiu W; Cai W
    Front Endocrinol (Lausanne); 2021; 12():743900. PubMed ID: 34659126
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor location-dependent skip lateral cervical lymph node metastasis in papillary thyroid cancer.
    Lee YS; Shin SC; Lim YS; Lee JC; Wang SG; Son SM; Kim IJ; Lee BJ
    Head Neck; 2014 Jun; 36(6):887-91. PubMed ID: 23733708
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comprehensive analysis of clinicopathologic and sonographic features in thyroid cancer with skip lymph node metastasis: establish and assessment of a prediction nomogram.
    Jiwang L; Jinghui B; Fengqin F; Tao Y; Yuejiao Z
    Braz J Otorhinolaryngol; 2023; 89(5):101301. PubMed ID: 37579569
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical analysis of cervical lymph node metastasis risk factors in patients with papillary thyroid microcarcinoma.
    Luo Y; Zhao Y; Chen K; Shen J; Shi J; Lu S; Lei J; Li Z; Luo D
    J Endocrinol Invest; 2019 Feb; 42(2):227-236. PubMed ID: 29876836
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.